Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $90 from $92 and keeps an Outperform rating on the shares. Published first on ...
UBS analyst Michael Ward lowered the firm’s price target on MetLife (MET) to $95 from $96 and keeps a Buy rating on the shares. Published first on ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...